FDA Inspection
Arevipharma GmbHArevipharma GmbH – FDA Inspection, Jun 20, 2025
Record Details
This FDA Inspection record concerns Arevipharma GmbH, with an inspection on June 20, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · c286f0d5-f5e5-4af8-b1d5-56d82a663486
Inspection Facts
- Inspection number
- 1288700
- FDA center
- Human Drugs
Other FDA inspections of Arevipharma GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 8, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Arevipharma GmbH
- FDA Inspection 1141793 - 2019-09-16
- FDA Inspection 969875 - 2016-04-29
- FDA Inspection 808573 - 2012-11-16
- FDA Inspection 576014 - 2009-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.